SCHEMBL17907271

SCHEMBL17907271

COc1cc2c(c(O)c1OC)OC(c1ccccc1)C(=O)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
PABPC1 P11940 1/20 0.44
APEX1 P27695 1/20 0.44
RECQL P46063 1/20 0.44
EIF4H Q15056 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP19A1 P11511 4/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SIRT1 Q96EB6 3/20 0.40
ABCB1 P08183 2/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
TAS2R31 P59538 1/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28840935 0.81 CYP19A1 (0.46) KMT2AMEN1POLBGAAMAPT
SCHEMBL28879340 0.79 ABCG2 (0.42) KMT2AMEN1POLBGAAMAPT
SCHEMBL28513252 0.79 CYP19A1 (0.46) KMT2AMEN1POLBGAAMAPT
SCHEMBL17907267 0.77 KMT2A (0.50) KMT2AMEN1POLBGAAMAPT
SCHEMBL29204371 0.77 CYP19A1 (0.42) KMT2AMEN1POLBGAAMAPT
SCHEMBL17503283 0.76 NPC1 (0.45) KMT2AMEN1POLBGAAMAPT
SCHEMBL664362 0.75 CYP19A1 (0.46) KMT2AMEN1POLBGAAMAPT
SCHEMBL29085240 0.75 CYP19A1 (0.47) KMT2AMEN1POLBGAAMAPT
SCHEMBL10425234 0.74 KDM4E (0.46) NPC1RAB9ASIRT1ABCB1ABCG2
SCHEMBL4951187 0.74 POLB (0.42) KMT2APOLBGAAMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3042897-B1 COMPOUND, MEDICINE, ANTI-INFLAMMATORY AGENT, COSMETIC, FOOD AND DRINK, AND METHOD FOR PRODUCING THE COMPOUND AMINO UP CO LTD (JP) 2019-09-11 EP disclosed
US-9573920-B2 Compound, medicine, anti-inflammatory, cosmetic, food and drink, and method for producing compound AMINO UP CHEMICAL CO., LTD (JP) 2017-02-21 US disclosed
US-20160207901-A1 COMPOUND, MEDICINE, ANTI-INFLAMMATORY, COSMETIC, FOOD AND DRINK, AND METHOD FOR PRODUCING COMPOUND Amino Up Co., Ltd. (JP) 2016-07-21 US disclosed
EP-3042897-A1 COMPOUND, MEDICINE, ANTI-INFLAMMATORY, COSMETIC, FOOD AND DRINK, AND METHOD FOR PRODUCING COMPOUND Amino Up Chemical Co., Ltd. (JP) 2016-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207901-A1 COMPOUND, MEDICINE, ANTI-INFLAMMATORY, COSMETIC, FOOD AND DRINK, AND METHOD FOR PRODUCING COMPOUND MPO, TNF, CUTA KMT2A 3025/4885MEN1 201/4885POLB 2261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.